Development and internal validation of prognostic models to predict negative health outcomes in older patients with multimorbidity and polypharmacy in general practice. Issue 10 (22nd October 2020)

• Record Type: Journal Article
• Authors: Müller, Beate S; Uhlmann, Lorenz; Ihle, Peter; Stock, Christian; von Buedingen, Fiona; Beyer, Martin; Gerlach, Ferdinand M; Perera, Rafael; Valderas, Jose Maria; Glasziou, Paul; van den Akker, Marjan; Muth, Christiane
• Is Part Of: BMJ open. Volume 10:Issue 10(2020)
• Publication Date: 2020-10-22
• Subjects: primary care -- therapeutics -- geriatric medicine -- health services administration & management; Medicine -- Research -- Periodicals; 610.72
• DOI: 10.1136/bmjopen-2020-039747
• Languages: English
• ISSNs: 2044-6055

Abstract

Abstract : Background: Polypharmacy interventions are resource-intensive and should be targeted to those at risk of negative health outcomes. Our aim was to develop and internally validate prognostic models to predict health-related quality of life (HRQoL) and the combined outcome of falls, hospitalisation, institutionalisation and nursing care needs, in older patients with multimorbidity and polypharmacy in general practices. Methods: Design : two independent data sets, one comprising health insurance claims data (n=592 456), the other data from the PRIoritising MUltimedication in Multimorbidity (PRIMUM) cluster randomised controlled trial (n=502). Population : ≥60 years, ≥5 drugs, ≥3 chronic diseases, excluding dementia. Outcomes : combined outcome of falls, hospitalisation, institutionalisation and nursing care needs (after 6, 9 and 24 months) (claims data); and HRQoL (after 6 and 9 months) (trial data). Predictor variables in both data sets : age, sex, morbidity-related variables (disease count), medication-related variables (European Union-Potentially Inappropriate Medication list (EU-PIM list)) and health service utilisation. Predictor variables exclusively in trial data : additional socio-demographics, morbidity-related variables (Cumulative Illness Rating Scale, depression), Medication Appropriateness Index (MAI), lifestyle, functional status and HRQoL (EuroQol EQ-5D-3L). Analysis : mixed regression models, combined with stepwise variable selection, 10-fold cross validation and sensitivity analyses. Results: Most important predictors of EQ-5D-3L at 6 months in best model (Nagelkerke's R² 0.507) were depressive symptoms (−2.73 (95% CI: −3.56 to −1.91)), MAI (−0.39 (95% CI: −0.7 to −0.08)), baseline EQ-5D-3L (0.55 (95% CI: 0.47 to 0.64)). Models based on claims data and those predicting long-term outcomes based on both data sets produced low R² values. In claims data-based model with highest explanatory power (R²=0.16), previous falls/fall-related injuries, previous hospitalisations, age, number of involved physicians and disease count were most important predictor variables. Conclusions: Best trial data-based model predicted HRQoL after 6 months well and included parameters of well-being not found in claims. Performance of claims data-based models and models predicting long-term outcomes was relatively weak. For generalisability, future studies should refit models by considering parameters representing well-being and functional status.